OSR Holdings, Inc. Logo

OSR Holdings, Inc.

Acquires biopharma R&D platforms to build a diverse portfolio of healthcare therapies.

OSRH | US

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
10900 NE 4TH STREET, SUITE 2300, 98004 BELLEVUE
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

OSR Holdings, Inc. is a global healthcare holding company that operates on a hub-and-spoke model. The company's strategy involves acquiring or partnering with biopharmaceutical firms that possess innovative, proprietary R&D platforms rather than single assets. Through this approach, OSR Holdings builds a diverse portfolio of therapies and healthcare solutions, including the development of oral immunotherapies for cancer treatment. The company's stated mission is to accelerate healthcare innovation to improve health and wellness outcomes worldwide and enhance the quality of life for patients and their families.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all OSR Holdings, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OSR Holdings, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for OSR Holdings, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Biotech firm using enzyme tech for pharma, healthcare, and bioprocess CDMO services.
South Korea
092040
AMICUS THERAPEUTICS, INC. Logo
Develops advanced therapies for rare lysosomal storage disorders.
United States of America
FOLD
AMINOLOGICS CO.,LTD. Logo
Manufactures high-purity chiral amino acids & APIs for pharma, chemical, and food industries.
South Korea
074430
Amneal Pharmaceuticals, Inc. Logo
Develops & commercializes essential medicines: generics, injectables & specialty drugs.
United States of America
AMRX
Amphastar Pharmaceuticals, Inc. Logo
Develops and manufactures complex injectable, intranasal, and inhalation pharmaceutical products.
United States of America
AMPH
Amylyx Pharmaceuticals, Inc. Logo
Developing novel therapies for neurodegenerative diseases like ALS and Wolfram syndrome.
United States of America
AMLX
AN2 Therapeutics, Inc. Logo
Developing novel small molecule drugs for infectious diseases and oncology using boron chemistry.
United States of America
ANTX
Develops approved cannabinoid medicines for pain, epilepsy, and heart failure.
United Kingdom
ANAN
ANAPTYSBIO, INC Logo
Clinical-stage biotech developing immunology therapies for autoimmune and inflammatory diseases.
United States of America
ANAB
Develops qPCR diagnostic kits and robotic automation systems for clinical and research laboratories.
Türkiye
ANGEN

Talk to a Data Expert

Have a question? We'll get back to you promptly.